In vivo multimodal imaging of adenosine A1 receptors in neuroinflammation after experimental stroke
Fecha
2021Autor
Joya, Ana
Ardaya Franco, María Isabel
Garbizu, Maider
Plaza García, Sandra
Gómez Vallejo, Vanessa
Padró, Daniel
Gutiérrez Martín, Juan José
Ríos, Xabier
Ramos Cabrer, Pedro
Cossío Arrieta, Unai
Pulagam, Krishna Reddy
Higuchi, Makoto
Cavaliere, Fabio
Matute Almau, Carlos José
Martín Muñoz, Abraham
Metadatos
Mostrar el registro completo del ítem
Theranostics 11(1) : 410-425 (2021)
Resumen
Adenosine A(l) receptors (A(l)ARs) are promising imaging biomarkers and targets for the treatment of stroke. Nevertheless, the role of A(l)ARs on ischemic damage and its subsequent neuroinflammatory response has been scarcely explored so far.
Methods: In this study, the expression of A(1)ARs after transient middle cerebral artery occlusion (MCAO) was evaluated by positron emission tomography (PET) with [F-18]CPFPX and immunohistochemistry (IHC). In addition, the role of AIARs on stroke inflammation using pharmacological modulation was assessed with magnetic resonance imaging (MRI), PET imaging with [F-18]DPA-714 (TSPO) and [F-18]FLT (cellular proliferation), as well as IHC and neurofunctional studies.
Results: In the ischemic territory, [F-18]CPFPX signal and IHC showed the overexpression of A(l)ARs in microglia and infiltrated leukocytes after cerebral ischemia. Ischemic rats treated with the AAR agonist ENBA showed a significant decrease in both [F-18]DPA-714 and [F-18]FLT signal intensities at day 7 after cerebral ischemia, a feature that was confirmed by IHC results. Besides, the activation of A(l)AR promoted the reduction of the brain lesion, as measured with T2W-MRI, and the improvement of neurological outcome including motor, sensory and reflex responses. These results show for the first time the in vivo PET imaging of A(l)AR expression after cerebral ischemia in rats and the application of [F-18]FLT to evaluate glial proliferation in response to treatment.
Conclusion: Notably, these data provide evidence for A(l)AR playing a key role in the control of both the activation of resident glia and the de novo proliferation of microglia and macrophages after experimental stroke in rats.